Overview

Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The study aims to evaluate H. pylori eradication rate in diabetic patients by using novel 10-day levofloxacin-based concomitant therapy compared with conventional 10-day sequential therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Chung-Tai Wu
Collaborator:
Ministry of Health and Welfare, Taiwan
Treatments:
Amoxicillin
Clarithromycin
Levofloxacin
Metronidazole
Ofloxacin
Pantoprazole